financetom
Business
financetom
/
Business
/
France's Vivendi reduces stake in Telecom Italia to 18.4%
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
France's Vivendi reduces stake in Telecom Italia to 18.4%
Mar 21, 2025 1:38 PM

March 21 (Reuters) - Vivendi on Friday said it

has reduced its ownership in Telecom Italia (TIM) to 18.4% from

23.8%, in line with its earlier strategic decision to divest

from the Italian telecom operator.

After further sales made post-March 18, the Paris-listed

group now owns 19.32% of the ordinary shares and voting rights,

and 13.87% of the share capital in the Italian telecom operator,

the company said in a statement.

This month Vivendi's CEO Arnaud de Puyfontaine confirmed the

company intended to sell its stake in TIM, as the Paris-listed

group no longer considers the investment to be strategic.

"When we are in a position to be able to exit the company

in good terms, we'll do it," he told analysts in a post-result

call.

Vivendi first invested in TIM in 2015.

The former Italian phone monopoly last year became the first

telecom incumbent in a major European country to opt for a full

separation of its fixed-line network, selling it to a consortium

led by U.S. fund KKR.

Vivendi opposed the grid sale, and is challenging the move

in court.

In February, state-backed financial conglomerate Poste

became TIM's second-largest shareholder after Vivendi

by acquiring a 9.8% stake from state lender Cassa Depositi e

Prestiti, a move backed by leading officials in Prime Minister

Giorgia Meloni's office.

Sources told Reuters Poste was considering raising its

stake further.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved